ETOPOSIDE Drug Patent Profile
✉ Email this page to a colleague
When do Etoposide patents expire, and what generic alternatives are available?
Etoposide is a drug marketed by Mylan, Accord Hlthcare, Dash Pharms, Dash Pharms Natco, Fresenius Kabi Usa, Hikma, Hospira, Meitheal, Pharmachemie Bv, Pierre Fabre, Teva Parenteral, Teva Pharms Usa, Watson Labs, and Watson Labs Inc. and is included in fifteen NDAs.
The generic ingredient in ETOPOSIDE is etoposide. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the etoposide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Etoposide
A generic version of ETOPOSIDE was approved as etoposide by HIKMA on July 17th, 1995.
Summary for ETOPOSIDE
US Patents: | 0 |
Applicants: | 14 |
NDAs: | 15 |
Finished Product Suppliers / Packagers: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 90 |
Clinical Trials: | 1,581 |
Patent Applications: | 1,692 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ETOPOSIDE |
DailyMed Link: | ETOPOSIDE at DailyMed |
Recent Clinical Trials for ETOPOSIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Fujian Cancer Hospital | Phase 2 |
Hirva Mamdani | Phase 2 |
Biotheus Inc. | Phase 2/Phase 3 |
Pharmacology for ETOPOSIDE
Drug Class | Topoisomerase Inhibitor |
Mechanism of Action | Topoisomerase Inhibitors |
Medical Subject Heading (MeSH) Categories for ETOPOSIDE
Anatomical Therapeutic Chemical (ATC) Classes for ETOPOSIDE
US Patents and Regulatory Information for ETOPOSIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan | ETOPOSIDE | etoposide | CAPSULE;ORAL | 075635-001 | Sep 19, 2001 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hospira | ETOPOSIDE | etoposide | INJECTABLE;INJECTION | 074320-001 | Aug 30, 1995 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Dash Pharms Natco | ETOPOSIDE | etoposide | INJECTABLE;INJECTION | 203507-001 | Nov 20, 2017 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Teva Parenteral | ETOPOSIDE | etoposide | INJECTABLE;INJECTION | 074510-001 | Jun 29, 1995 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hospira | ETOPOSIDE | etoposide | INJECTABLE;INJECTION | 074351-001 | Aug 30, 1995 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Labs | ETOPOSIDE | etoposide | INJECTABLE;INJECTION | 074228-001 | Oct 15, 1996 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |